Showing results (71-80 of 135) with videos related to
Sort By:
Pageof 14
Journal of the American Medical Directors Association|July 11, 2025
Change in Distressed Behavior in Dementia During the COVID-19 Pandemic in Veterans Affairs Community Living CentersThomas A Bayer, Frank DeVone, Mriganka Singh, et al.Biomedicines|February 25, 2023
Search Strategy Analysis of 5xFAD Alzheimer Mice in the Morris Water Maze Reveals Sex- and Age-Specific Spatial Navigation DeficitsCarolina Quintanilla Sánchez, Franziska W Schmitt, Nadine Curdt, et al.Free Radical Biology & Medicine|June 28, 2002
Possible mechanisms of APP-mediated oxidative stress in Alzheimer's diseaseGerd Multhaup, Stefan Scheuermann, Andrea Schlicksupp, et al.International Journal of Molecular Sciences|October 14, 2022
Ablation of the Presynaptic Protein Mover Impairs Learning Performance and Decreases Anxiety Behavior in MiceEva Maria Schleicher, Thomas A Bayer, Trendelina Iseni, et al.Journal of the American Geriatrics Society|October 17, 2025
Post-Hospitalization Outcomes for Veterans Receiving Age-Friendly Health Systems 4M CareThomas A Bayer, Malisa Barber, Christopher Halladay, et al.Frontiers in Aging Neuroscience|January 24, 2019
18F-FDG-PET Detects Drastic Changes in Brain Metabolism in the Tg4-42 Model of Alzheimer's DiseaseCaroline Bouter, Philipp Henniges, Timon N Franke, et al.Journal of Alzheimer'S Disease : JAD|December 6, 2013
Aβ38 in the brains of patients with sporadic and familial Alzheimer's disease and transgenic mouse modelsJochim Reinert, Henrik Martens, Melanie Huettenrauch, et al.Molecular Neurodegeneration|April 4, 2014
Abundance of Aβ₅-x like immunoreactivity in transgenic 5XFAD, APP/PS1KI and 3xTG mice, sporadic and familial Alzheimer's diseaseErika Avendaño Guzmán, Yvonne Bouter, Bernhard C Richard, et al.Journal of Alzheimer'S Disease Reports|March 4, 2025
Chronic exposure to a synthetic cannabinoid improves cognition and increases locomotor activity in Tg4-42 Alzheimer's disease miceFrederik W Ott, Marius E Sichler, Caroline Bouter, et al.Neurobiology of Aging|September 28, 2011
No improvement after chronic ibuprofen treatment in the 5XFAD mouse model of Alzheimer's diseaseAntje Hillmann, Stefanie Hahn, Stephan Schilling, et al.Pageof 14